Descheduling Cannabis Will Not Relegate Its Sale Exclusively to Pharmacies; It Will Empower States to Regulate Cannabis as They Seem Fit
Descheduling Cannabis Will Not Relegate Its Sale Exclusively to Pharmacies; It Will Empower States to Regulate Cannabis as They Seem Fit
By Paul Armentano A recently featured article in CBE, entitled “Implications of the MORE Act and Possible Federal Legalization of Cannabis,” opines that removing the cannabis plant from the federal Controlled Substances Act – as initially proposed by the Marijuana Opportunity Reinvestment and Expungement Act of 2019 – will reclassify it as a prescription-only substance. Having spent more than 25…
View On WordPress















